Digital therapeutics (DTx) developer Curio has raised over $10 million in first-round financing that will be used to fund the rollout of its MamaLift Plus app for postpartum depression (PPD
Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights.
We hear the safety instructions every time we fly – secure your own oxygen mask before assisting your children. This advice serves as a powerful metaphor for women's health.